🔎 Trials Near Me

Nyumbani › Scleroderma › Texas › Houston

Majaribio ya kliniki ya Scleroderma katika Houston, TX

Masomo 9 ya Scleroderma yanatafuta washiriki katika vituo vya Houston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

InaajiriHatua 3
  • The University of Texas Health Science Center at Houston, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07497087

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

InaajiriHatua 1
  • UT MD Anderson Cancer Center, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345

Platform Clinical Study for Conquering Scleroderma

InaajiriHatua 2
  • University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06195072

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

InaajiriHatua 1/2
  • Nkarta Investigational Site, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

InaajiriHatua 2
  • Artiva Investigational Site Bellaire, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT06991114

A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis

InaajiriHatua 2
  • The University of Texas Health Science Center at Houston, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Jul 2026 · NCT06827977

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

InaajiriHatua 1/2
  • MD Anderson Cancer Center, Houston
  • The University of Texas Health Science Center at Houston, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT06434363

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

Inaajiri
  • The University of Texas Health Science Center at Houston, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Jun 2025 · NCT05989763

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

InaajiriHatua 2
  • aTyr Investigative Site, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2025 · NCT05892614

Majaribio ya Scleroderma katika miji mingine

Masomo mengine katika Houston

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.